GNMSF vs GILD: Which Stock is Better?
Side-by-side comparison of Genmab A/S and Gilead Sciences Inc in 2026
GNMSF
Genmab A/S
—
GILD
Gilead Sciences Inc
$133.21
Key Metrics Comparison
| Metric | GNMSF | GILD | Winner |
|---|---|---|---|
| Market Cap | $14.85B | $160.15B | GILD |
| P/E Ratio | 18.39 | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GNMSF
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GNMSF or GILD a better investment?
Comparing GNMSF and GILD: Genmab A/S has a market cap of $14.85B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GNMSF and GILD?
GNMSF (Genmab A/S) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GNMSF or GILD?
Based on P/E ratios, GILD trades at a lower multiple (17.5x vs 18.4x).
Which is growing faster: GNMSF or GILD?
Both GNMSF and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GNMSF or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GNMSF or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $14.85B for GNMSF.
Should I buy GNMSF or GILD in 2026?
Both GNMSF and GILD have investment merit. GNMSF trades at $N/A while GILD trades at $133.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GNMSF and GILD stock?
Key differences: Market Cap ($14.85B vs $160.15B), P/E Ratio (18.4x vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GNMSF or GILD in 2026?
The choice between GNMSF and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GNMSF and GILD?
GNMSF (Genmab A/S) has a market cap of $14.85B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.